Skinvisible, Inc. (SKVI)
OTCMKTS: SKVI · Delayed Price · USD
0.101
0.00 (0.00%)
Apr 12, 2024, 2:21 PM EDT - Market closed

Skinvisible Statistics

Total Valuation

Skinvisible has a market cap or net worth of $276,930. The enterprise value is $6.43 million.

Market Cap 276,930
Enterprise Value 6.43M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Skinvisible has 4.54 million shares outstanding.

Shares Outstanding 4.54M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.40%
Owned by Institutions (%) n/a
Float 4.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 13.85
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 321.46
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio 0.01
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.92

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -3,164.33%
Return on Capital (ROIC) n/a
Revenue Per Employee $10,000
Profits Per Employee -$2.58M
Employee Count 2
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

In the past 12 months, Skinvisible has paid $3.11 million in taxes.

Income Tax 3.11M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.02% in the last 52 weeks. The beta is -0.39, so Skinvisible's price volatility has been lower than the market average.

Beta (1Y) -0.39
52-Week Price Change +2.02%
50-Day Moving Average 0.08
200-Day Moving Average 0.08
Relative Strength Index (RSI) 38.42
Average Volume (30 Days) 1,064

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Skinvisible had revenue of $20,000 and -$5.15 million in losses. Loss per share was -$1.13.

Revenue 20,000
Gross Profit 1,229
Operating Income -490,377
Pretax Income -2.38M
Net Income -5.15M
EBITDA -471,603
EBIT -490,374
Loss Per Share -$1.13
Full Income Statement

Balance Sheet

The company has $888 in cash and $6.15 million in debt, giving a net cash position of -$6.15 million or -$1.36 per share.

Cash & Cash Equivalents 888
Total Debt 6.15M
Net Cash -6.15M
Net Cash Per Share -$1.36
Equity / Book Value -9.02M
Book Value Per Share -1.99
Working Capital -3.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$77,157 and capital expenditures -$9,333, giving a free cash flow of -$86,490.

Operating Cash Flow -77,157
Capital Expenditures -9,333
Free Cash Flow -86,490
FCF Per Share -$0.02
Full Cash Flow Statement

Margins

Gross margin is 6.15%, with operating and profit margins of -2,451.89% and -25,768.53%.

Gross Margin 6.15%
Operating Margin -2,451.89%
Pretax Margin -11,912.20%
Profit Margin -25,768.53%
EBITDA Margin -2,358.02%
EBIT Margin -2,451.87%
FCF Margin -432.45%

Dividends & Yields

Skinvisible does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1,861.01%
FCF Yield -31.23%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 4, 2019. It was a reverse split with a ratio of 1:50.

Last Split Date Jan 4, 2019
Split Type Reverse
Split Ratio 1:50

Scores

Skinvisible has an Altman Z-Score of -373.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -373.92
Piotroski F-Score 1